Page 2 - Medicine Trading Down News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Medicine trading down. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Medicine Trading Down Today - Breaking & Trending Today

Morgan Stanley Trims Disc Medicine (NASDAQ:IRON) Target Price to $40.00

Disc Medicine (NASDAQ:IRON – Get Free Report) had its price objective cut by Morgan Stanley from $75.00 to $40.00 in a research note issued on Tuesday, Benzinga reports. The firm presently has an “equal weight” rating on the stock. Morgan Stanley’s target price suggests a potential upside of 26.78% from the stock’s previous close. A […] ....

Raymond James , Stifel Nicolaus , Kevin Bitterman , Geode Capital Management , Venture Fund Xlp Atlas , Citigroup Inc , Renaissance Technologies , Millennium Management , Morgan Stanley , Disc Medicine Inc , Securities Exchange Commission , Disc Medicine , Get Free Report , Medicine Trading Down , Director Kevin Bitterman , Exchange Commission , Venture Fund , Capital Management , Point Capital Management , Disc Medicine Daily ,

Editas Medicine, Inc. (NASDAQ:EDIT) Receives $15.00 Consensus PT from Analysts

Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the nine brokerages that are covering the firm, MarketBeat.com reports. Four research analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 12 month price target […] ....

Baisong Mei , Gilmore Neil Oneill , Investors Services , York Mellon Corp , Editas Medicine Inc , Securities Exchange Commission , Jpmorgan Chase Co , Wells Fargo Company , Editas Medicine , Get Free Report , Neilo Neill , Exchange Commission , New York Mellon Corp , Medicine Trading Down , Get Free , Leber Congenital Amaurosis , Editas Medicine Daily ,

Disc Medicine (NASDAQ:IRON) Earns Buy Rating from HC Wainwright

Disc Medicine (NASDAQ:IRON) Earns Buy Rating from HC Wainwright
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Kevin Bitterman , Disc Medicine Company Profile , Citadel Advisors , Perceptive Advisors , Vanguard Group Inc , Venture Fund Xlp Atlas , Disc Medicine Inc , Frazier Life Sciences Management , Cantor Fitzgerald , Morgan Stanley , Disc Medicine , Free Report , Medicine Trading Down , Get Free Report , Director Kevin Bitterman , Venture Fund , Capital Partners , Disc Medicine Daily ,

Disc Medicine (NASDAQ:IRON) Rating Reiterated by Wedbush

Disc Medicine (NASDAQ:IRON) Rating Reiterated by Wedbush
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Kevin Bitterman , Securities Exchange Commission , Frazier Life Sciences Management , Perceptive Advisors , Disc Medicine Inc , Morgan Stanley , Venture Fund Xlp Atlas , Vanguard Group Inc , Citadel Advisors , Cantor Fitzgerald , Disc Medicine , Free Report , Medicine Trading Down , Director Kevin Bitterman , Venture Fund , Exchange Commission , Capital Partners , Get Free Report , Disc Medicine Daily ,

Editas Medicine (NASDAQ:EDIT) Stock Price Down 8.9%

Editas Medicine (NASDAQ:EDIT) Stock Price Down 8.9%
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Editas Medicine Inc , Editas Medicine Company Profile , Cantor Fitzgerald , Jpmorgan Chase Co , Investors Services , Wells Fargo Company , York Mellon Corp , Editas Medicine , Get Free Report , Medicine Trading Down , New York Mellon Corp , Leber Congenital Amaurosis , Editas Medicine Daily ,